Статті в журналах з теми "Facteur VIII (FVIII)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Facteur VIII (FVIII)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Labrouche, S., C. Vergnes, J. Constans, A. Berard, and G. Freyburger. "Augmentation du facteur VIII (FVIII) : recherche d’une implication moléculaire du LRP." Journal des Maladies Vasculaires 30, no. 4 (September 2005): 6. http://dx.doi.org/10.1016/s0398-0499(05)86244-4.
Yada, Koji, Kenichi Ogiwara, Masaru Shibata, Midori Shima, and Keiji Nogami. "Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII." Thrombosis and Haemostasis 105, no. 06 (2011): 989–98. http://dx.doi.org/10.1160/th10-12-0781.
Yada, Koji, Keiji Nogami, Kenichi Ogiwara, Katsumi Nishiya, Masahiro Takeyama, and Midori Shim. "Effects of Anti-FVIII Inhibitors On Factor VIIa/Tissue Factor-Catalyzed Activation and Inactivation of Factor VIII." Blood 114, no. 22 (November 20, 2009): 3169. http://dx.doi.org/10.1182/blood.v114.22.3169.3169.
Nakajima, Yuto, Koji Yada, Keiji Nogami, and Midori Shima. "A Novel Mechanism of Factor VIIa/Tissue Factor (TF)-Catalyzed Activation and Inactivation of B-Domain-Deleted Factor VIII in the Early Initiation Phases of Coagulation." Blood 132, Supplement 1 (November 29, 2018): 1162. http://dx.doi.org/10.1182/blood-2018-99-115645.
Ogiwara, Kenichi, Keiji Nogami, Masahiro Okuda, Katsumi Nishiya, Masahiro Takeyama, and Midori Shima. "Interactions of Factor VIII with Tissue Factor Contributes to the Acceleration of Factor Xa Generation in the Initiation Phase of Blood Coagulation." Blood 114, no. 22 (November 20, 2009): 3177. http://dx.doi.org/10.1182/blood.v114.22.3177.3177.
Ogiwara, Kenichi, Keiji Nogami, Tetsuhiro Soeda, Tomoko Matsumoto, Katsumi Nishiya, and Midori Shima. "Mechanisms of Factor VIII Activation by Recombinant Factor VIIa Analog through Tissue Factor-Independent Manner." Blood 112, no. 11 (November 16, 2008): 1028. http://dx.doi.org/10.1182/blood.v112.11.1028.1028.
Soeda, Tetsuhiro, Keiji Nogami, Tomoko Matsumoto, Kenichi Ogiwara, Katsumi Nishiya, and Midori Shima. "Tissue Factor-Dependent Activation of Factor VIII by Factor VIIa in the Early Phase of Blood Coagulation." Blood 112, no. 11 (November 16, 2008): 1036. http://dx.doi.org/10.1182/blood.v112.11.1036.1036.
Shoko, Furukawa, Keiji Nogami, Kenichi Ogiwara, and Midori Shima. "Mechanism of Tissue Factor (TF) Enhancing Factor (F)VIII Activity on FXa Generation in Initial Phase of Coagulation and Interaction Between TF and FVIII C2 Domain." Blood 128, no. 22 (December 2, 2016): 1391. http://dx.doi.org/10.1182/blood.v128.22.1391.1391.
Radtke, Klaus-Peter, Dean Chamberlain, John H. Griffin, and Andrew J. Gale. "Whole Blood Thromboelastogram Assays Demonstrate Prolonged Factor VIIIa Potency for Recombinant Disulfide Bond-Stabilized Factor VIII Variants." Blood 104, no. 11 (November 16, 2004): 2976. http://dx.doi.org/10.1182/blood.v104.11.2976.2976.
Meeks, Shannon, Ernest T. Parker, Amy L. Dunn, John F. Healey, and Pete Lollar. "Proteolytically Inactivatable Factor VIII is Less Immunogenic than Factor VIII in a Murine Hemophilia A Model." Blood 114, no. 22 (November 20, 2009): 27. http://dx.doi.org/10.1182/blood.v114.22.27.27.
Yada, Koji, Keiji Nogami, Kenichi Ogiwara, and Midori Shima. "A novel mechanism of Enhancing the Haemostatic Effect in the Combination with Recombinant Factor VIII and Activated Prothrombin Complex Concentrate(APCC) in Hemophilia A Patients with Inhibitor." Blood 118, no. 21 (November 18, 2011): 1178. http://dx.doi.org/10.1182/blood.v118.21.1178.1178.
Messer, Amanda S., Barbara Ulmasov, Yogesh Kumar, Kanagasabai Vadivel, Degang Zhong, Philip Fay, and S. Paul Bajaj. "Epitope Mapping of a Monoclonal Antibody to Factor VIII That Inhibits Factor IXa:Factor VIIIa Interaction and Thrombin Activation of Factor VIII." Blood 118, no. 21 (November 18, 2011): 1177. http://dx.doi.org/10.1182/blood.v118.21.1177.1177.
Zakas, Philip, Kristopher Knight, Ernest T. Parker, H. Trent Spencer, Eric Gaucher, and Christopher B. Doering. "Bioengineering Coagulation Factor VIII through Ancestral Protein Reconstruction." Blood 126, no. 23 (December 3, 2015): 123. http://dx.doi.org/10.1182/blood.v126.23.123.123.
Okayama, Yusuke, Masato Bingo, Kazuki Sakatoku, Hiroshi Okamura, Satoru Nanno, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, and Hirohisa Nakamae. "The safety of the combination therapy of recombinant factor VIIa and plasma-derived factor VIIa and factor X for refractory hemorrhage in acquired hemophilia A." Blood Coagulation & Fibrinolysis 34, no. 6 (July 19, 2023): 419–22. http://dx.doi.org/10.1097/mbc.0000000000001243.
Ogiwara, Kenichi, Midori Shima, and Keiji Nogami. "Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms." Thrombosis and Haemostasis 106, no. 10 (2011): 665–74. http://dx.doi.org/10.1160/th11-04-0264.
Rao, LV, and SI Rapaport. "Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa." Blood 75, no. 5 (March 1, 1990): 1069–73. http://dx.doi.org/10.1182/blood.v75.5.1069.1069.
Rao, LV, and SI Rapaport. "Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa." Blood 75, no. 5 (March 1, 1990): 1069–73. http://dx.doi.org/10.1182/blood.v75.5.1069.bloodjournal7551069.
Minami, Hiroaki, Keiji Nogami, Takehisa Kitazawa, Kunihiro Hattori, and Midori Shima. "FVIII Heavy Chain Enhances Tenase Activity Induced By FVIIIa Mimicking Bispesific Antibody, ACE910." Blood 124, no. 21 (December 6, 2014): 1481. http://dx.doi.org/10.1182/blood.v124.21.1481.1481.
Doshi, Bhavya, Courtney Cox, Bagirath Gangadharan, Christopher B. Doering, and Shannon L. Meeks. "Factor VIII Supplementation Improves Recombinant VIIa Initiated Thrombin Generation in Hemophilia A Inhibitor Patient Plasmas." Blood 118, no. 21 (November 18, 2011): 28. http://dx.doi.org/10.1182/blood.v118.21.28.28.
Wilhelm, Amelia R., Nicole A. Parsons, Benjamin J. Samelson-Jones, Robert J. Davidson, Charles T. Esmon, Rodney M. Camire, and Lindsey A. George. "Activated protein C has a regulatory role in factor VIII function." Blood 137, no. 18 (May 6, 2021): 2532–43. http://dx.doi.org/10.1182/blood.2020007562.
Gale, Andrew J., Diana Rozenshteyn, and Justin Riceberg. "The Neutrophil Proteases, Elastase and Cathepsin G, May Modulate the Activity of Factor VIII." Blood 108, no. 11 (November 16, 2006): 1716. http://dx.doi.org/10.1182/blood.v108.11.1716.1716.
Yada, Koji, and Keiji Nogami. "Novel Insights and New Developments Regarding Coagulation Revealed by Studies of the Anti-Factor IXa (Activated Factor IX)/Factor X Bispecific Antibody, Emicizumab." Arteriosclerosis, Thrombosis, and Vascular Biology 40, no. 5 (May 2020): 1148–54. http://dx.doi.org/10.1161/atvbaha.120.312919.
Addiego, Joseph E., Edward Gomperts, Liu Shu-Len, Patricia Bailey, Suzanne G. Courter, Martin L. Lee, Gerald G. Neslund, Henry S. Kingdon, and Michael J. Griffith. "Treatment of Hemophilia A with a Highly Purified Factor VIII Concentrate Prepared by Anti-FVIIIc Immunoaffinity Chromatography." Thrombosis and Haemostasis 67, no. 01 (1992): 019–27. http://dx.doi.org/10.1055/s-0038-1648373.
Neuenschwander, Pierre F. "Evidence of Abnormal Coagulation: Production of Factor VIII α-Fragment In Vivo." Blood 106, № 11 (16 листопада 2005): 1020. http://dx.doi.org/10.1182/blood.v106.11.1020.1020.
Bloem, Esther, Henriet Meems, Maartje van den Biggelaar, Koen Mertens, and Alexander B. Meijer. "Factor VIII Region 1811–1818 Is Involved in Factor IXa Binding and Factor VIIIa Stability." Blood 120, no. 21 (November 16, 2012): 3357. http://dx.doi.org/10.1182/blood.v120.21.3357.3357.
Wilhelm, Amelia R., Nicole A. Parsons, Charles T. Esmon, Rodney M. Camire, and Lindsey A. George. "In Vivo hemostatic Significance of Activated Protein C in Factor VIIIa Regulation." Blood 134, Supplement_1 (November 13, 2019): 93. http://dx.doi.org/10.1182/blood-2019-124493.
Healey, John F., Ernest Parker, and John (Pete) S. Lollar. "Comparative Decay Rates of Human, Rhesus Macaque, Cynomolgus, and Porcine Activated Factor VIII." Blood 114, no. 22 (November 20, 2009): 3164. http://dx.doi.org/10.1182/blood.v114.22.3164.3164.
Rozenshteyn, Diana, and Andrew J. Gale. "Cathepsin G, a leukocyte protease, activates coagulation factor VIII." Thrombosis and Haemostasis 99, no. 01 (2008): 44–51. http://dx.doi.org/10.1160/th07-08-0495.
van 't Veer, C., TM Hackeng, C. Delahaye, JJ Sixma, and BN Bouma. "Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor." Blood 84, no. 4 (August 15, 1994): 1132–42. http://dx.doi.org/10.1182/blood.v84.4.1132.1132.
van 't Veer, C., TM Hackeng, C. Delahaye, JJ Sixma, and BN Bouma. "Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor." Blood 84, no. 4 (August 15, 1994): 1132–42. http://dx.doi.org/10.1182/blood.v84.4.1132.bloodjournal8441132.
Mazurier, Claudine, Armelle Parquet-Gernez, and Maurice Goudemand. "Validation of a Procedure for Potency Assessing of a High Purity Factor VIII Concentrate -Comparison of Different Factor VIII Coagulant Assays and Effect of Prediluent." Thrombosis and Haemostasis 64, no. 02 (1990): 251–55. http://dx.doi.org/10.1055/s-0038-1647295.
Takeyama, Masahiro, Keiji Nogami, Tomoko Matsumoto, Tetsuhiro Soeda, Tsukasa Suzuki, Kunihiro Hattori, and Midori Shima. "Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity." Thrombosis and Haemostasis 103, no. 01 (2010): 94–102. http://dx.doi.org/10.1160/th09-05-0338.
Peerlinck, Kathelijne, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson, et al. "Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A." Blood 93, no. 7 (April 1, 1999): 2267–73. http://dx.doi.org/10.1182/blood.v93.7.2267.
Peerlinck, Kathelijne, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson, et al. "Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A." Blood 93, no. 7 (April 1, 1999): 2267–73. http://dx.doi.org/10.1182/blood.v93.7.2267.407k21_2267_2273.
Ponder, Katherine P. "FIXing Factor VIII inhibitors." Blood 119, no. 2 (January 12, 2012): 325–26. http://dx.doi.org/10.1182/blood-2011-11-389486.
Zhong, Degang, Evgueni L. Saenko, Midori Shima, Matthew Felch, and Dorothea Scandella. "Some Human Inhibitor Antibodies Interfere With Factor VIII Binding to Factor IX." Blood 92, no. 1 (July 1, 1998): 136–42. http://dx.doi.org/10.1182/blood.v92.1.136.413k35_136_142.
Hsu, Ting-Chang, Kathleen P. Pratt, and Arthur R. Thompson. "The factor VIII C1 domain contributes to platelet binding." Blood 111, no. 1 (January 1, 2008): 200–208. http://dx.doi.org/10.1182/blood-2007-01-068957.
Grushin, Kirill, Jaimy Miller, Daniela Dalm, and Svetla Stoilova-McPhie. "Factor VIII organisation on nanodiscs with different lipid composition." Thrombosis and Haemostasis 113, no. 04 (July 2015): 741–49. http://dx.doi.org/10.1160/th14-09-0725.
Hakeos, William, Hongzhi Miao, Nongnuch Sirachainan, Geoffrey Kemball-Cook, Evgueni Saenko, Randal Kaufman, and Steven Pipe. "Hemophilia A Mutations within the Factor VIII A2-A3 Subunit Interface Destabilize Factor VIIIa and Cause One-stage/ Two-stage Activity Discrepancy." Thrombosis and Haemostasis 88, no. 11 (2002): 781–87. http://dx.doi.org/10.1055/s-0037-1613302.
Strijbis, Viola J. F., Ka Lei Cheung, Pavlina Konstantinova, Ying Poi Liu, Sander J. van Deventer, and Mettine H. A. Bos. "Evaluation of a Blood Coagulation Factor IX Variant That Functions Independently of Factor VIII As an Alternative Treatment for Hemophilia A." Blood 134, Supplement_1 (November 13, 2019): 1110. http://dx.doi.org/10.1182/blood-2019-124120.
Sen, Prosenjit, Curtis A. Clark, Ramakrishnan Gopalakrishnan, Ulla Hedner, Charles T. Esmon, Usha R. Pendurthi, and L. Vijaya Rao. "Factor VIIa binding to endothelial cell protein C receptor: Differences between mouse and human systems." Thrombosis and Haemostasis 107, no. 05 (2012): 951–61. http://dx.doi.org/10.1160/th11-09-0672.
Lannert, Kerry W., Hilary S. Gammill, Barbara A. Konkle, and Jill M. Johnsen. "The Ability of Von Willebrand Factor (VWF) to Bind Factor VIII (FVIII) Can Decrease during Pregnancy." Blood 124, no. 21 (December 6, 2014): 4244. http://dx.doi.org/10.1182/blood.v124.21.4244.4244.
Rolli, Veronique, Nathalie Enjolras, Cecile Ducasse, Marie-Helene Rodriguez, Thomas Weimer, Hans-Peter Hauser, Claude Negrier, and Jean-Luc Plantier. "Generation of Factor VIII Molecules Partially Resistant to Activated Protein C." Blood 104, no. 11 (November 16, 2004): 1729. http://dx.doi.org/10.1182/blood.v104.11.1729.1729.
Markovitz, Rebecca C., John F. Healey, Ernest T. Parker, Shannon L. Meeks, and Pete Lollar. "The diversity of the immune response to the A2 domain of human factor VIII." Blood 121, no. 14 (April 4, 2013): 2785–95. http://dx.doi.org/10.1182/blood-2012-09-456582.
Golino, Paolo, Massimo Ragni, Plinio Cirillo, Annalisa Scognamiglio, Amelia Ravera, Chiara Buono, Angela Guarino, et al. "Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits." American Journal of Physiology-Heart and Circulatory Physiology 278, no. 5 (May 1, 2000): H1507—H1516. http://dx.doi.org/10.1152/ajpheart.2000.278.5.h1507.
Jenkins, P. Vincent, Jan Freas, Kyla M. Schmidt, Qian Zhou, and Philip J. Fay. "Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex." Blood 100, no. 2 (July 15, 2002): 501–8. http://dx.doi.org/10.1182/blood-2001-12-0361.
Wakabayashi, Hironao, Jennifer Wintermute, and Philip J. Fay. "Stabilizing Factor VIIIa By Combining Mutations That Modulate Inter-Subunit Interactions and Proteolytic Inactivation." Blood 122, no. 21 (November 15, 2013): 3572. http://dx.doi.org/10.1182/blood.v122.21.3572.3572.
Gangadharan, Bagirath, H. Trent Spencer, Ernest T. Parker, and Christopher B. Doering. "High-Level Expression of Porcine Factor VIII from Murine Mesenchymal Stem Cells." Blood 104, no. 11 (November 16, 2004): 5281. http://dx.doi.org/10.1182/blood.v104.11.5281.5281.
Cooper, Adrian, Zhong Liang, Francis Castellino, and Elliot Rosen. "Cloning and Characterization of the Murine Coagulation Factor X Gene." Thrombosis and Haemostasis 83, no. 05 (2000): 732–35. http://dx.doi.org/10.1055/s-0037-1613901.
Ogiwara, Kenichi, Tomoko Matsumoto, Katsumi Nishiya, Masahiro Takeyama, Midori Shima, and Keiji Nogami. "Mechanisms of human neutrophil elastase-catalysed inactivation of factor VIII(a)." Thrombosis and Haemostasis 105, no. 06 (2011): 968–80. http://dx.doi.org/10.1160/th10-12-0777.